Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avonex Combination Trial (ACT)
NCT00112034Phase 4Completed
- Sponsor
- Biogen
- Start
- Jun 2003
- Primary completion
- Jun 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methotrexate, methylprednisolone injection in multiple sclerosis (MS), sponsored by Biogen. Started Jun 2003; status: completed.
02
Drugs
methotrexatemethylprednisolone injection
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00112034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112034.